# FDA Inspection 787333 - Balin, Martin S., MD, PhD - August 17, 2012

Source: https://www.keypedia.com/records/fda_inspections/balin-martin-s-md-phd/3446b227-6a8b-450e-9d18-4f5439a3d438
Source feed: FDA_Inspections

> FDA Inspection 787333 for Balin, Martin S., MD, PhD on August 17, 2012. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 787333
- Company Name: Balin, Martin S., MD, PhD
- Inspection Date: 2012-08-17
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 937676 - 2015-08-06](https://www.keypedia.com/records/fda_inspections/balin-martin-s-md-phd/6d5d4251-1eb4-469c-9816-ad5c61a2cbc4)
- [FDA Inspection 821704 - 2013-03-13](https://www.keypedia.com/records/fda_inspections/balin-martin-s-md-phd/0d60f2d7-2848-4fb5-b346-d1a06fcdbea4)
- [FDA Inspection 631548 - 2009-11-13](https://www.keypedia.com/records/fda_inspections/balin-martin-s-md-phd/097907c6-a0f4-4a73-ad7d-73779d6682a5)

Company: https://www.keypedia.com/companies/balin-martin-s-md-phd/232947f1-1af3-4eac-b82f-56351b78508c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d